Viatris Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Viatris Inc with three other
companies in this sector in UNITED STATES :
Regeneron Pharmaceuticals Incorporated
sales of $7.86 billion
of which 59%
Daiichi Sankyo Company Limited
of which 93%
was Prescription drugs), and
of which 84%
was CSL Behring).
During the year ended December of 2019, sales at
Viatris Inc were $11.50 billion.
a very small
increase of 0.6%
versus 2018, when the company's sales were $11.43 billion.
Despite this increase, sales are still
below the level achieved in 2017, when Viatris Inc
reported sales of $11.91 billion.
Sales of Rest of World saw an increase
that was more than double the company's growth rate: sales were up
5.5% in 2019, from
$3.04 billion to $3.21 billion.
Not all segments of Viatris Inc experienced an increase in sales in 2019:
sales of Europe fell 3.1% to $4.05 billion.